MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
164.58%
Quick Ratio
164.58%
Cash Ratio
154.23%
Debt to Asset Ratio
77.47%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease assets
    • Cash and cash equivalents
    • Restricted cash
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
29,834
45,766
47,638
45,379
Accounts receivable due from spn - related party
0
360
426
882
Accounts receivable
233
157
351
-
Prepaid expenses and other current assets
1,770
3,093
3,112
2,424
Total current assets
31,837
49,376
51,527
48,685
Property and equipment, net
6,854
7,635
8,578
9,622
Operating lease assets
70,228
72,483
74,669
76,794
Restricted cash
8,668
8,668
8,668
8,668
Other non-current assets
31
31
31
31
Total assets
117,618
138,193
143,473
143,800
Accounts payable
2,338
1,682
1,677
2,200
Accrued expenses and other current liabilities
2,863
3,972
6,382
5,809
Accrued liabilities due to spn - related party
3,278
3,278
4,450
13,453
Operating lease liabilities
10,865
10,390
9,920
9,478
Total current liabilities
19,344
19,322
22,429
30,940
Operating lease liabilities, net of current portion
69,634
72,576
75,333
77,956
Other long-term liabilities
2,141
2,077
2,014
1,954
Total liabilities
91,119
93,975
99,776
110,850
Common stock, 0.001 par value 360,000,000 shares authorized at march 31, 2026 and december 31, 2025 9,592,326 and 9,556,466 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
10
10
9
9
Additional paid-in capital
1,018,805
1,016,611
1,000,756
998,213
Accumulated other comprehensive loss
-
-
0
0
Accumulated deficit
-992,316
-972,403
-957,068
-965,272
Total stockholders' equity
26,499
44,218
43,697
32,950
Total liabilities and stockholders' equity
117,618
138,193
143,473
143,800
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$29,834K Prepaid expenses andother current assets$1,770K Accounts receivable$233K Operating lease assets$70,228K Total current assets$31,837K Restricted cash$8,668K Property and equipment,net$6,854K Other non-currentassets$31K Total assets$117,618K Total liabilities andstockholders' equity$117,618K Total liabilities$91,119K Total stockholders'equity$26,499K Accumulated deficit-$992,316K Operating leaseliabilities, net of current...$69,634K Total currentliabilities$19,344K Other long-termliabilities$2,141K Additional paid-in capital$1,018,805K Common stock, 0.001 parvalue 360,000,000...$10K Operating leaseliabilities$10,865K Accrued liabilities dueto spn - related...$3,278K Accrued expenses andother current...$2,863K Accounts payable$2,338K

Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics, Inc. (MCRB)